Nov. 27 Company Quick Takes: Orexo, GAIA in second deal for substance abuse digital therapy; plus PDUFA date for Verrica's skin infection candidate and $25M fol

Orexo gets U.S. rights to GAIA's alcohol abuse digital therapeutic
Orexo AB (SSE:ORX) licensed exclusive U.S. rights from GAIA AG to vorvida, a

Read the full 229 word article

User Sign In